A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
Condition(s):HealthyLast Updated:August 17, 2010Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:August 17, 2010Completed
Condition(s):HealthyLast Updated:January 28, 2021Withdrawn
Condition(s):Anxiety DisorderLast Updated:January 28, 2021Completed
Condition(s):EpilepsyLast Updated:June 30, 2022Completed
Condition(s):Panic DisorderLast Updated:January 28, 2021Terminated
Condition(s):Stereotypical Prolonged SeizuresLast Updated:March 1, 2024Enrolling by invitation
Condition(s):Healthy Study ParticipantsLast Updated:May 17, 2021Completed
Condition(s):HealthyLast Updated:August 25, 2010Completed
Condition(s):HealthyLast Updated:August 25, 2010Completed
Condition(s):Panic DisorderLast Updated:January 28, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.